{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T05:08:36Z","timestamp":1790744916816,"version":"4.1.0"},"reference-count":18,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1097\/inf.0b013e3182706b89","type":"journal-article","created":{"date-parts":[[2012,8,25]],"date-time":"2012-08-25T06:44:37Z","timestamp":1345877077000},"page":"e20-e25","source":"Crossref","is-referenced-by-count":58,"title":["The Disease Burden of Invasive Meningococcal Serogroup B Disease in Canada"],"prefix":"10.1097","volume":"32","author":[{"given":"Julie A.","family":"Bettinger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David W.","family":"Scheifele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Le Saux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott A.","family":"Halperin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy","family":"Vaudry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond","family":"Tsang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-11-20210202","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1097\/INF.0b013e31819040e7","article-title":"Canadian Immunization Monitoring Program, Active (IMPACT). The impact of childhood meningococcal serogroup C conjugate vaccine programs in Canada.","volume":"28","author":"Bettinger","year":"2009","journal-title":"Pediatr Infect Dis J"},{"key":"R2-11-20210202","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1128\/CVI.00529-09","article-title":"Updated postlicensure surveillance of the meningococcal C conjugate vaccine in England and Wales: effectiveness, validation of serological correlates of protection, and modeling predictions of the duration of herd immunity.","volume":"17","author":"Campbell","year":"2010","journal-title":"Clin Vaccine Immunol"},{"key":"R3-11-20210202","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1016\/j.vaccine.2009.01.026","article-title":"Rapid identification of herd effects with the introduction of serogroup C meningococcal conjugate vaccine in Ontario, Canada, 2000-2006.","volume":"27","author":"Kinlin","year":"2009","journal-title":"Vaccine"},{"key":"R4-11-20210202","doi-asserted-by":"crossref","first-page":"e71","DOI":"10.1097\/INF.0b013e3181f59f6d","article-title":"Immunogenicity of two investigational serogroup B meningococcal vaccines in the first year of life: a randomized comparative trial.","volume":"29","author":"Snape","year":"2010","journal-title":"Pediatr Infect Dis J"},{"key":"R5-11-20210202","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1086\/656741","article-title":"Multicenter, open-label, randomized phase II controlled trial of an investigational recombinant Meningococcal serogroup B vaccine with and without outer membrane vesicles, administered in infancy.","volume":"51","author":"Findlow","year":"2010","journal-title":"Clin Infect Dis"},{"key":"R6-11-20210202","doi-asserted-by":"crossref","first-page":"5023","DOI":"10.1016\/j.vaccine.2010.05.014","article-title":"Measuring antigen-specific bactericidal responses to a multicomponent vaccine against serogroup B meningococcus.","volume":"28","author":"Giuliani","year":"2010","journal-title":"Vaccine"},{"key":"R7-11-20210202","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1128\/CVI.00304-10","article-title":"Immunogenicity and safety of a multicomponent meningococcal serogroup B vaccine and a quadrivalent meningococcal CRM197 conjugate vaccine against serogroups A, C, W-135, and Y in adults who are at increased risk for occupational exposure to meningococcal isolates.","volume":"18","author":"Kimura","year":"2011","journal-title":"Clin Vaccine Immunol"},{"key":"R8-11-20210202","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1093\/pch\/14.1.33","article-title":"IMPACT after 17 years: lessons learned about successful networking.","volume":"14","author":"Scheifele","year":"2009","journal-title":"Paediatr Child Health"},{"key":"R9-11-20210202","doi-asserted-by":"crossref","first-page":"e130","DOI":"10.1155\/2009\/871071","article-title":"Profile of serogroup Y meningococcal infections in Canada: Implications for vaccine selection.","volume":"20","author":"Le Saux","year":"2009","journal-title":"Can J Infect Dis Med Microbiol"},{"key":"R10-11-20210202","doi-asserted-by":"crossref","first-page":"3140","DOI":"10.1073\/pnas.95.6.3140","article-title":"Multilocus sequence typing: a portable approach to the identification of clones within populations of pathogenic microorganisms.","volume":"95","author":"Maiden","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"R11-11-20210202","first-page":"861","article-title":"Association of meningococcal serogroups with the course of disease in the Netherlands, 1959-83.","volume":"65","author":"Spanjaard","year":"1987","journal-title":"Bull World Health Organ"},{"key":"R12-11-20210202","doi-asserted-by":"crossref","first-page":"e979","DOI":"10.1542\/peds.2006-0281","article-title":"Multicenter surveillance of invasive meningococcal infections in children.","volume":"118","author":"Kaplan","year":"2006","journal-title":"Pediatrics"},{"key":"R13-11-20210202","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1128\/JCM.00601-06","article-title":"Invasive meningococcal disease in Quebec, Canada, due to an emerging clone of ST-269 serogroup B meningococci with serotype antigen 17 and serosubtype antigen P1.19 (B:17:P1.19).","volume":"44","author":"Law","year":"2006","journal-title":"J Clin Microbiol"},{"key":"R14-11-20210202","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1086\/520303","article-title":"Complications and sequelae of meningococcal disease in Quebec, Canada, 1990-1994.","volume":"26","author":"Erickson","year":"1998","journal-title":"Clin Infect Dis"},{"key":"R15-11-20210202","doi-asserted-by":"crossref","first-page":"e117","DOI":"10.1093\/cid\/cir500","article-title":"Comparative long-term adverse effects elicited by invasive group B and C meningococcal infections.","volume":"53","author":"Gottfredsson","year":"2011","journal-title":"Clin Infect Dis"},{"key":"R17-11-20210202","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1001\/jama.1995.03520290042027","article-title":"The changing epidemiology of invasive meningococcal disease in Canada, 1985 through 1992. Emergence of a virulent clone of Neisseria meningitidis.","volume":"273","author":"Whalen","year":"1995","journal-title":"JAMA"},{"key":"R18-11-20210202","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1017\/S0950268809002428","article-title":"Morbidity, mortality and spatial distribution of meningococcal disease, 1974-2007.","volume":"137","author":"Howitz","year":"2009","journal-title":"Epidemiol Infect"},{"issue":"pt 6","key":"R19-11-20210202","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1099\/jmm.0.05078-0","article-title":"Nucleotide sequence-based typing of meningococci directly from clinical samples.","volume":"52","author":"Diggle","year":"2003","journal-title":"J Med Microbiol"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0b013e3182706b89","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T01:32:18Z","timestamp":1620955938000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006454-201301000-00011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1]]},"references-count":18,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0b013e3182706b89","relation":{},"ISSN":["0891-3668"],"issn-type":[{"value":"0891-3668","type":"print"}],"subject":[],"published":{"date-parts":[[2013,1]]}}}